Our degree programs
We offer undergraduate, postgraduate coursework and research (PhD) programs in the core disciplines of Chemical Engineering, Industrial Chemistry and Food Science & Technology. Students benefit from world-class facilities, and academic staff who are among the best in their fields, with years of collective teaching and research experience.
Research is our passion
Researchers at the School of Chemical Engineering are passionate about providing solutions to major world issues through innovation. They focus on critical areas that affect the future, including energy, health, the environment, water and food, and are often called upon to work with both industry and government.
Sign up to ChemEng Connect e-News
Connect with us to find out the latest news and upcoming events of the School. Each issue includes a feature interview with an industry leader in the wider field of Chemical Engineering and/or Food Science and Technology.

Latest News & Events

Forum FRAN 2014 – the Third Forum of the French Researchers in Australia Network
19 November 2014

The largest ever forum of French researchers in Australia launched its opening yesterday and was held over two days (Tuesday 18 and Wednesday 19 November) at UNSW Australia (the University of New South Wales) in Sydney.

2014 Honours Poster Award Winner
19 November 2014

2014 School of Chemical Engineering Honours Poster Award Winner

6 January 2015
9.00am to 4.00pm

FEATURED: INTERVIEW WITH DR CHRIS ROBERTS

UNSW Chemical Engineering Industry Interview Series #1

Associate Professor Patrick Spicer speaks with UNSW Chemical Engineering alumnus Dr Chris Roberts about innovation in the wider field of chemical engineering and biotechnology. Exploring how the current environment has changed for entrepreneurs and what challenges they face. How the digital movement has impacted on the advancement of technology and how the principles of engineering have shaped Chris' perspective on business and assisted his journey to becoming CEO of Cochlear Limited.

FEATURED: THE HY-CYCLE

Hy-Cycle - Australia's first fuel cell bike

UNSW researchers have built an Australian-first bicycle that can take riders up to 125 kilometres on a single battery charge and $2 of hydrogen.

The Hy-Cycle, created by a team including Associate Professor Kondo-Francois Aguey-Zinsou and Technical Officer Paul Brockbank from the School of Chemical Engineering, is powered by a hydrogen fuel cell.

The fuel cell provides electrical assistance with pedalling, enabling the rider to easily travel long distances or up hills.

This could make the Hy-Cycle a low-cost, sustainable transport option.

- See more at: http://www.engineering.unsw.edu.au/chemical-engineering/news/australia%E...

UNSW researchers have built an Australian-first bicycle that can take riders up to 125 kilometres on a single battery charge and $2 of hydrogen.

The Hy-Cycle, created by a team including Associate Professor Kondo-Francois Aguey-Zinsou and Technical Officer Paul Brockbank from the School of Chemical Engineering, is powered by a hydrogen fuel cell.

The fuel cell provides electrical assistance with pedalling, enabling the rider to easily travel long distances or up hills. This could make the Hy-Cycle a low-cost, sustainable transport option.

Australia's first fuel cell bicycle, the Hy-Cycle was launched on Open Day 2014.

Read more.

ALUMNI PROFILE - MICHAEL FARRELL

ALUMNI PROFILE - MICHAEL FARRELL

Michael Farrell holds a Bachelor of Engineering in Chemical Engineering with first-class honors from UNSW Australia, a Master of Science in Chemical Engineering from the Massachusetts Institute of Technology, and an M.B.A. from the MIT Sloan School of Management.

Mr Farrell has been Chief Executive Officer for ResMed since March 2013. Prior to that appointment, Mr Farrell served as President – Americas for ResMed from 2011 to 2013. He was previously senior vice president of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development. Before joining ResMed in 2000, Mr Farrell worked in management consulting, biotechnology, chemicals, and metals manufacturing at Arthur D. Little, Genzyme Corporation, The Dow Chemical Company, and BHP Billiton. Mr Farrell sits on the ResMed board of directors and on the board of directors of the Medical Device Manufacturers’ Association (MDMA) in Washington, DC, as well as the California Healthcare Institute (CHI), the La Jolla Playhouse, and the New Children’s Museum in San Diego, California.